Table 1. Potential Biomarker Identification^a.

no	RT (min)	mass-to-charge ratio	type	sample	identified compound	trend
						group II versus group I	group III versus group II
1	1.87	338.0814	M + H	urine	3-indole carboxylic acid glucuronide	↑**	↓
2	3.34	237.0826	M – H	urine	cystathionine sulfoxide	↑**	↓
3	3.43	323.0629	M – H	serum	uridine 5′-monophosphate	↓**	↑##
4	3.44	159.1062	M – H	urine	oxoadipic acid	↑**	↓##
5	4.06	217.0212	M – H	urine	3-hydroxysebacic acid	↓*
6	4.20	273.1535	M + H	urine	estradiol	↓**	↑
7	4.25	191.1064	M – H	urine	citric acid	↑**	↓##
8	4.70	307.0663	M + Na	serum	xanthosine	↑**	↓
9	4.82	369.2309	M – H	serum	3-oxo-4,6-choladienoic acid	↓**
10	5.57	209.1193	M + H	urine	l-kynurenine	↓**	↑##
11	5.70	243.1032	M + H	urine	thymidine	↑**	↓##
12	6.21	407.2895	M – H	serum	cholic acid	↑*	↓#
13	9.11	317.2158	M – H	serum	leukotriene A4	↓**
14	11.56	594.3764	M + FA – H	serum	lysoPC (20:1(11Z))	↓**	↑#
15	13.57	308.0930	M + H	urine	glutathione	↑**	↓##

^aCompared to group I: *P < 0.05 and **P < 0.01; compared to group II: ^#P < 0.05 and ^##P < 0.01.